Number needed to screen: lives saved over 20 years of follow-up in mammographic screening

Journal of Medical Screening
L TabarStephen W Duffy

Abstract

To estimate the number needed to screen with mammography to save one life, based on a stated amount of screening activity and long-term follow-up for breast cancer death. A randomised controlled trial of mammographic screening for breast cancer, with 77,080 women invited to screening and 55,985 not invited. The invited group was offered screening for seven years. Follow-up continued for a total of just over 20 years. Number needed to screen for seven years to save one life over 20 years was calculated by dividing the number screened (not the number invited) by the total number of lives saved. Similarly, we calculated the number of mammographic examinations required to save one life. We estimate that the number of women needed to screen for seven years to save one life over 20 years is 465 (95% CI 324-819). The number of mammographic examinations needed to save one life was 1499 (95% CI 1046-2642). The number needed to screen to save one life is smaller than has been reported in the past. Mammographic screening is effective in absolute terms as well as relative. Long-term follow-up allowed us to estimate the absolute benefit with greater accuracy.

Citations

Apr 4, 2009·BMC Medical Informatics and Decision Making·John D Keen, James E Keen
Apr 4, 2009·BMC Medical Informatics and Decision Making·Stephen W Duffy
Feb 13, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Denise R AberleKathleen Brown
Sep 24, 2005·AJR. American Journal of Roentgenology·Tommy E CupplesJames C Reynolds
Nov 21, 2008·AJR. American Journal of Roentgenology·Carrie B HruskaMichael K O'Connor
Jan 25, 2011·AJR. American Journal of Roentgenology·R Edward Hendrick, Mark A Helvie
Nov 18, 2004·AJR. American Journal of Roentgenology·Harald O StolbergIsabelle Trop
Feb 26, 2010·World Journal of Surgery·Ava KwongCatherine L Y Choi
Nov 22, 2008·Archives of Gynecology and Obstetrics·Meredith NobleKaren Schoelles
Nov 23, 2012·The New England Journal of Medicine·Robert A SmithMette Kalager
Apr 8, 2010·The Breast : Official Journal of the European Society of Mastology·Jon M Greif
Jun 2, 2009·Cancer Epidemiology·Jennifer M GierischCelette Sugg Skinner
Sep 1, 2004·Radiologic Clinics of North America·Robert A SmithTony H H Chen
Sep 2, 2014·Radiología·J Cervera DevalJ J Zulueta
May 1, 2010·Lancet·Wendy S AtkinUNKNOWN UK Flexible Sigmoidoscopy Trial Investigators
Feb 24, 2012·AJR. American Journal of Roentgenology·R Edward Hendrick, Mark A Helvie
Jul 17, 2009·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Wendy S RubinsteinAlfred W Rademaker
Dec 11, 2008·Alzheimer Disease and Associated Disorders·Cristina GeroldiGiovanni B Frisoni
Oct 1, 2006·Expert Review of Pharmacoeconomics & Outcomes Research·Idris Guessous, Jacques Cornuz
Jun 6, 2013·The Cochrane Database of Systematic Reviews·Peter C Gøtzsche, Karsten Juhl Jørgensen
Feb 6, 2013·AJR. American Journal of Roentgenology·Stephen A Feig
Sep 26, 2020·The Korean Journal of Internal Medicine·Dong-Hyun JooJung-Kyu Lee

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.